Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Follicular Lymphoma Follicular Lymphoma for September/October 2020 Survey quantifies COVID-19’s impact on oncology, More must reads Follicular Lymphoma for January/February 2020 Adding lymphopenia component ‘improves’ FLIPI, REGN1979 shows good activity in pretreated aggressive B-NHL, More must readsFollicular Lymphoma for November/December 2019 Survival Data Reported From Largest CAR T Trial in B-Cell Lymphoma, Newly identified genetic changes contribute to transformation of follicular lymphoma, Rituximab maintenance has a durable benefit in follicular lymphoma, Armored CAR T Cells Elicit Responses in NHL Patients, More must readsFollicular Lymphoma for September/October 2019 Best treatment approach for early stage follicular lymphoma is unclear, ASCT may cure follicular lymphoma for some rituximab-naive patients, More must readsFollicular Lymphoma for July/August 2019 Obinutuzumab-lenalidomide combo shows promise in relapsed/refractory FL, More must readsPages1 2 3 4 5 last »
